Medical/Pharmaceuticals

Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability

Company attributes B+ rating to progress related to its Human Rights Management Declaration, eco-friendly shipping box and the establishment of an internal ESG Committee SEOUL, South Korea, Nov. 10, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total so...

2023-11-10 20:00 4998

Shaping Global Policy: IFPA's Psoriatic Disease Response Index in the Western Pacific

STOCKHOLM, Nov. 10, 2023 /PRNewswire/ -- Psoriatic disease, recognized as a serious noncommunicable disease by the World Health Organization (WHO), impacts millions worldwide. A pioneering advocacy tool, the Psoriatic Disease Response Index, has emerged to facilitate a vital policy discussion, dr...

2023-11-10 19:18 5185

H2U Secures Strategic Investment from InnoTherapy as Recognition from Seoul Clinical Laboratories (SCL)

H2U platform enters the South Korean healthcare sector, driving AI-powered data analytics to expand their digital health offerings TAIPEI, Nov. 10, 2023 /PRNewswire/ -- H2U, Taiwan's premier digital health brand, proudly announced another successful round of funding this year after receiving rec...

2023-11-10 17:48 4137

TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS

Jaime Arango, Chief Financial Officer, Jens Schröder as Chief Medical Officer andRachel Mooney, Chief Communications Officer BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics , a global biotechnology company advancing a pipeline of cell therapies based on...

2023-11-09 19:01 4555

Noah Launches "Play The Full Game" Campaign with Singaporean Football Legend Fandi Ahmad as Brand Ambassador

SINGAPORE, Nov. 9, 2023 /PRNewswire/ -- Noah, the telehealth platform tailored for men and created by Ordinary Folk, is pleased to announce the launch of its "Play The Full Game" campaign and the appointment ofFandi Ahmad as Noah's brand ambassador. The campaign aims to empower men to have the co...

2023-11-09 14:31 3422

West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets

SINGAPORE, Nov. 9, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Nilesh Shah to serve as Vice President and General Manager of Emerging Mark...

2023-11-09 12:58 11308

European Wellness and DXN Sign MoU to Establish World-Class Wellness Centre!

CYBERJAYA, Malaysia, Nov. 9, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group) has signed a Memorandum of Understanding with DXN Holdings Berhad (DXN) to jointly develop and establish a comprehensive wellness centre that draws from the extensive expertise and experience of both p...

2023-11-09 11:46 4291

DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells

Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ -- DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function...

2023-11-09 08:15 3116

Dr. Jinzi J. Wu Presents at the 10th International Workshop on HBV Cure 2023

HANGZHOU and SHAOXING, China, Nov. 9, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that Dr.Jinzi J. Wu, Founder, Chairman and CEO of Ascletis was invited to attend and have a presentation at the 10th International Workshop on HBV Cure 2023 held atBoston, Unit...

2023-11-09 08:10 6559

Telix to Present at Jefferies London Healthcare Conference 2023

MELBOURNE, Australia, Nov. 9, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that DrChristian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies London Healthcare Conference 2023. The presentation will take place o...

2023-11-09 04:51 2855

Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema at American Academy of Ophthalmology

TAIPEI, Nov. 8, 2023 /PRNewswire/ --  * AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of doses of 0.5, 1, 2, and 4 mg in DME patients. * Data combining all 4 cohorts showed mean improvement in Best Corrected Visual Acc...

2023-11-08 23:23 2697

Seoul National University Bundang Hospital (SNUBH) Secures Prestigious GHA Accreditation, Reinforcing Its Position as a Premier Global Medical Travel Destination

PALM BEACH GARDENS, Fla., Nov. 8, 2023 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH), one of South Korea's most prestigious healthcare institutions, is delighted to announce that it has achieved a second consecutive term of Accreditation with Excellence fromGlobal Healthcare ...

2023-11-08 19:00 3757

The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit Delivered Insights on the Future of Healthcare

SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit (AHLSICS), hosted by ASK Health Asia and the SingHealth Duke-NUS Global Health Institute (SDGHI), in collaboration with the World Economic Forum, successfully concluded in Singapore on 1s...

2023-11-08 14:30 3672

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement withDenmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of Telix's investigational prostate cancer imaging agent, Illuc...

2023-11-08 13:00 3125

Simulare Medical Launches the Alveolar Bone Graft Simulator

ABG Simulator New Addition to Further Support Cleft Reconstructive Surgical Training TAIPEI, Nov. 8, 2023 /PRNewswire/ -- Simulare Medical, a division of Smile Train Inc. (New York) announces the launch of the Alveolar Bone Graft (ABG) simulator, the latest high-fidelity surgical item in its gro...

2023-11-08 10:00 2953

SP Manufacturing expands into the United States

New Design and Development Center in California provides advanced engineering and development services for SP Manufacturing's global customers.  SAN DIEGO, Calif., Nov. 8, 2023 /PRNewswire/ -- SP Manufacturing, a leader in electronic manufacturing services for mission-critical industries, announc...

2023-11-08 10:00 3358

Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand

* After a successful pilot in the Philippines, five DocquityCare Patient Access Programs (PAPs)have been launched in Thailand * DocquityCare PAP will support more than 100 hospitals and 250 healthcare professionals (HCPs) to improve patient care for those with cancer and other life-threatenin...

2023-11-08 10:00 4458

Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs

* During the event, Antengene will review promising data of its R&D pipeline, includingATG-031 (anti-CD24 monoclonal antibody), ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), ATG-037 (CD73 inhibitor), and ATG-008 (dual mTORC1/2 inhibitor). * The vir...

2023-11-08 08:30 2975

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

* ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years. * ESR1 mutations are present in up to 40% of ER+, HER2- advance...

2023-11-08 02:01 3392

Discovery Life Sciences Announces New CEO

Greg Herrema to Spearhead Next Phase of Global Biospecimen and Biomarker Company's Expansion HUNTSVILLE, Ala., Nov. 7, 2023 /PRNewswire/ -- Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced today the appointment ofGreg Herrema as its new chief executive officer. A lea...

2023-11-07 23:01 4039
1 ... 209210211212213214215 ... 380